Karius Test Report
The Karius laboratory is CLIA-certified and CAP-accredited to perform high-complexity clinical laboratory testing. Over 85% of specimens received by 8:30 AM (PT) Monday through Saturday are reported the next day. Details on the test reporting process can be found here.
Karius Test Performance Data
Analytical Performance & Clinical Validation
*Discordant Karius results included clinically-relevant pathogens such as Helicobacter pylori, EBV, and CMV that were determined not to be the primary cause of sepsis via adjudication. For a summary of the analytical validation see: kariusdx.com/validation.
AMR Clinical Validation Performance Summary
PPA = Positive Percent Agreement
NPA = Negative Percent Agreement
Overall Yield: Calculated by sum of presence and absence calls for an AMR marker, divided by the sum of all microbes in that drug class category that could have those markers Orthogonal confirmation methods included: blood culture, Vitek, Microscan Walkaway, Agar dilution, E test gradient strip, and other microbiology tools
*Samples chosen may not represent pathogen abundance distribution in targeted patient population
**False positives come from samples where orthogonal confirmation was limited
#SCCmec and mecA combined
For additional information on the Karius Test AMR detection capabilities, go here.
Access to Results
The Karius Test is available as a send-out test to hospitals. Karius Test results for existing customers are available via:
If you are a new customer and would like to place the first order for a Karius Test go here.
For any questions, please contact Customer Success, available via phone: (866) 452-7487 or email: firstname.lastname@example.org